September 29th 2023
Jeremy C. Jones, MD, discusses the applications of circulating tumor DNA testing in colorectal cancer.
August 10th 2021
Jeremy C. Jones, MD, discusses key lessons learned from the phase 3 KEYNOTE-177 trial.
July 20th 2021
Jeremy C. Jones, MD, discusses targeting HER2 alterations in colorectal cancer.
July 12th 2021
Jeremy C. Jones, MD, discusses the risk of interstitial lung disease with fam-trastuzumab deruxtecan-nxki in colorectal cancer.
June 21st 2021
Jeremy C. Jones, MD, discusses the clinical utility of pembrolizumab in microsatellite instability–high colorectal cancer.
June 15th 2021
Jeremy C. Jones, MD, discusses the importance of testing for microsatellite instability high in colorectal cancer.